tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

BioXcel Therapeutics Inc

BTAI
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.075USD
+0.008+11.94%
์ข…๊ฐ€ย 09-04 16:00๏ผˆET๏ผ‰
2.32M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

BioXcel Therapeutics Inc

0.075
+0.008+11.94%
๊ฐœ์š”
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

BTAI ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด BioXcel Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
2.32M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.02
์ฃผ๋‹น์ˆœ์ด์ต
-4.76
์ˆ˜์ต
642.00K
์ˆœ์ด์ต
-59.60M
ROE
-1.77K%
ROA
-207.56%

BioXcel Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 13, 2026
EPS / ์˜ˆ์ƒ
-0.49/-0.51
์ˆ˜์ต / ์˜ˆ์ƒ
182.00K/256.67K

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
80.15%-0.49
64.12%-0.54
86.60%-0.57
57.74%-2.18
25.84%-2.45
89.19%-1.50
64.59%-4.28
81.33%-5.15
88.76%-3.30
52.96%-13.89
61.28%-12.10
---27.60
---29.34
---29.52
---31.24
---63.41
----
----
----
----
์ˆ˜์ต
51.67%182.00K
22.62%206.00K
-30.05%256.00K
-54.21%98.00K
-89.13%120.00K
-71.13%168.00K
-2.66%366.00K
-37.24%214.00K
141.58%1.10M
182.52%582.00K
57.98%376.00K
148.91%341.00K
--457.00K
--206.00K
--238.00K
--137.00K
----
----
--0.00
--0.00
์ˆœ์ด์ต
23.32%-14.71M
-74.95%-12.69M
-15.53%-12.54M
-126.45%-30.91M
-131.20%-19.19M
72.92%-7.25M
51.21%-10.86M
72.96%-13.65M
84.49%-8.30M
49.26%-26.79M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.80M
-109.79%-54.81M
-55.92%-41.80M
-36.39%-37.67M
-19.32%-31.47M
-23.90%-26.13M
-8.31%-26.81M
์ˆœ์ด์ต๋ฅ 
49.44%-8084.07%
-42.68%-6160.68%
-65.17%-4900.39%
-394.50%-31541.84%
-2027.01%-15989.17%
6.20%-4317.86%
49.88%-2966.94%
56.92%-6378.50%
93.58%-751.72%
82.04%-4603.26%
74.30%-5919.15%
---14805.28%
---11710.07%
---25629.13%
---23028.57%
---80984.67%
----
----
----
----
์ด ์ด์ต๋ฅ 
711.50%87.91%
-140.78%-37.38%
168.72%87.50%
119.87%88.78%
-88.52%10.83%
6.27%91.67%
-41.64%-127.32%
-790.85%-446.73%
0.08%94.38%
-9.81%86.25%
-193.43%-89.89%
---50.15%
--94.31%
--95.63%
--96.22%
--91.97%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-13.94%362.69%
7.72%294.75%
-8.74%244.00%
14.05%243.63%
167.72%421.44%
121.64%273.62%
95.89%267.38%
116.54%213.61%
127.72%157.42%
133.90%123.46%
201.96%136.49%
--98.65%
--69.13%
--52.78%
--45.20%
--37.45%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
51.67%182.00K
22.62%206.00K
-30.05%256.00K
-54.21%98.00K
-89.13%120.00K
-71.13%168.00K
-2.66%366.00K
-37.24%214.00K
141.58%1.10M
182.52%582.00K
57.98%376.00K
148.91%341.00K
--457.00K
--206.00K
--238.00K
--137.00K
----
----
--0.00
--0.00
์˜์—… ์ด์ต
35.70%-10.19M
-1.23%-10.22M
1.71%-10.28M
-2.14%-14.03M
3.58%-15.85M
58.20%-10.10M
47.37%-10.46M
68.87%-13.74M
68.63%-16.44M
52.80%-24.16M
62.42%-19.88M
-13.19%-44.13M
-44.44%-52.41M
-62.64%-51.20M
-102.42%-52.89M
-45.42%-38.99M
-31.42%-36.29M
-19.34%-31.48M
-23.86%-26.13M
-8.25%-26.81M
์ˆœ์ด์ต
23.32%-14.71M
-74.95%-12.69M
-15.53%-12.54M
-126.45%-30.91M
-131.20%-19.19M
72.92%-7.25M
51.21%-10.86M
72.96%-13.65M
84.49%-8.30M
49.26%-26.79M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.80M
-109.79%-54.81M
-55.92%-41.80M
-36.39%-37.67M
-19.32%-31.47M
-23.90%-26.13M
-8.31%-26.81M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
13.69%28.70M
-10.24%33.91M
19.50%44.69M
-7.09%44.40M
-60.67%25.24M
-53.31%37.78M
-48.17%37.39M
-51.60%47.79M
-53.57%64.18M
-54.35%80.92M
-64.44%72.14M
-59.14%98.74M
-43.56%138.24M
-14.60%177.27M
-14.33%202.87M
-5.94%241.66M
-11.47%244.92M
5.48%207.56M
9.10%236.81M
8.81%256.93M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
310.92%137.15M
115.27%54.99M
142.55%53.93M
47.92%37.80M
22.31%33.38M
-18.85%25.55M
-18.46%22.23M
-35.15%25.56M
-21.46%27.29M
9.46%31.48M
-17.12%27.27M
68.57%39.41M
73.76%34.74M
79.78%28.76M
97.38%32.90M
60.17%23.38M
60.72%20.00M
29.80%16.00M
40.74%16.67M
-10.70%14.60M
์ด ์ž์‚ฐ
11.67%28.80M
-11.77%34.02M
17.16%44.92M
-8.39%44.79M
-60.59%25.79M
-53.15%38.57M
-47.98%38.34M
-51.33%48.89M
-53.29%65.44M
-54.29%82.32M
-64.20%73.70M
-58.97%100.45M
-43.56%140.10M
-14.66%180.10M
-14.03%205.85M
-6.32%244.82M
-11.69%248.24M
5.32%211.04M
8.87%239.44M
9.46%261.33M
๋ถ€์ฑ„ ์ด๊ณ„
8.09%144.26M
8.41%139.57M
6.80%140.38M
-0.61%133.71M
-4.49%133.46M
-16.77%128.74M
0.94%131.44M
-4.63%134.53M
4.10%139.74M
21.71%154.69M
0.88%130.21M
19.71%141.06M
59.85%134.23M
646.54%127.10M
626.30%129.08M
646.91%117.83M
513.12%83.97M
24.71%17.02M
34.23%17.77M
-11.43%15.78M
์ž๋ณธ ์ด๊ณ„
-7.24%-115.46M
-17.05%-105.54M
-2.54%-95.46M
-3.84%-88.92M
-44.91%-107.67M
-24.61%-90.17M
-64.76%-93.10M
-110.88%-85.63M
-1367.07%-74.30M
-236.52%-72.36M
-173.60%-56.51M
-131.98%-40.61M
-96.43%5.86M
-72.68%53.01M
-65.36%76.78M
-48.29%126.99M
-38.57%164.26M
3.90%194.02M
7.24%221.67M
11.14%245.56M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
51.51%-6.10M
1.94%-11.81M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.57M
31.98%-12.04M
44.87%-14.81M
56.53%-16.34M
39.34%-23.17M
66.18%-17.71M
30.48%-26.86M
-20.52%-37.58M
-15.42%-38.21M
-61.52%-52.35M
-93.85%-38.64M
-54.39%-31.19M
-47.90%-33.10M
-65.04%-32.41M
1.68%-19.93M
-5.75%-20.20M
์ˆœํˆฌ์ž
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
----
--0.00
--0.00
-5.26%-20.00K
100.00%0.00
100.00%0.00
100.00%0.00
81.00%-19.00K
62.03%-120.00K
95.56%-12.00K
-440.00%-17.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
1884.67%2.72M
-98.24%232.00K
32.06%5.65M
8166.96%37.53M
-97.42%137.00K
-50.42%13.20M
101.41%4.28M
--454.00K
2021.60%5.30M
10.26%26.63M
4146.00%2.12M
-100.00%0.00
-99.62%250.00K
--24.15M
--50.00K
42221.13%30.05M
-34.85%66.14M
-100.00%0.00
-100.00%0.00
-99.96%71.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

BioXcel Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 642.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.27M์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 44.69M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.50์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioXcel Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 44.92M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 17.16์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioXcel Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 140.38M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 6.80์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioXcel Therapeutics Inc์˜ ์ด์ž๋ณธ์€ -95.46M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -2.54์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioXcel Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -50.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.43์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioXcel Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 56.52M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 54.17์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -5.73์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 98.48์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -69.90M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -17.28์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -10887.38์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -313.95์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 74.45์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1271.66์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 244.00์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.74์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -167.91์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -57.83์ž…๋‹ˆ๋‹ค.

BioXcel Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioXcel Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -50.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.43์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ